XBioSpace

09/27/2024

“A 25-year-old woman with type 1 diabetes started producing her own insulin less than three months after receiving a transplant of reprogrammed stem cells” (extracted from her own body)

Now, a year has passed since the stem cell injection.
No dangerous spikes and drops in blood glucose levels.
No issues at all.

“I can eat sugar now,” - said the woman.

“They’ve completely reversed diabetes in the patient, who was requiring substantial amounts of insulin beforehand.” - James Shapiro (the University of Alberta).

“That’s remarkable. If this is applicable to other patients, it’s going to be wonderful.” - Daisuke Yabe (Kyoto University).

She is the first person with type 1 diabetes to receive this kind of transplant.

12/26/2023

Happy to announce that XBioSpace will be participating at the Healthspan XPRIZE 2030!

https://pop.xprize.org/teams/11771

06/15/2023

https://nvlpubs.nist.gov/nistpubs/ai/NIST.AI.100-1.pdf

05/05/2019

"Every day, 22 people die in the U.S. alone waiting for a compatible organ for transplant. For those with autoimmune disorders, even a matched organ won't last, as their immune system will still reject it. What if we could make universal stem cells to generate cells, tissues, and organs compatible with everyone? On a first step towards that, we performed an extreme immune makeover in human pluripotent stem cells using CRISPR/Cas9 to delete 4 rejection genes and add 3 tolerance genes. Tissues derived from these stem cells were protected from both adaptive and innate immune responses. Cars can last a long time if one keeps replacing the parts. So could people."

- Dr. Leo

XBioSpace - Augmenting human health.

Health and Longevity through personalized medicine and biological repair for all.

https://www.pnas.org/content/early/2019/04/29/1902566116

05/05/2019

Very happy to announce that Mr. Juan Carlos Durán, MBA will be joining the XBIOSPACE family as its Chief Officer.

Mr. Durán is a Sr. finance professional at the Intel Corporation, supporting manufacturing and strategic functions.

"I have experience in corporate finance, M&A, and business development in both Fortune 500 and small entrepreneurial companies. I hold a bachelor’s degrees in Finance and Marketing from Arizona State University and an MBA from Harvard Business School. Now I want to bring that expertise to XBioSpace as its Chief Financial Officer."

04/24/2019

Can we cure genetic diseases by rewriting DNA?

In a story of scientific discovery, chemical biologist David R. Liu shares a breakthrough: his lab's development of base editors that can rewrite DNA. This crucial step in genome editing takes the promise of CRISPR to the next level: if CRISPR proteins are molecular scissors, programmed to cut speci...

04/24/2019

Dr. Leonardo Ferreira on how CRISPR gene therapy would work for Sickle Cell Disease, fight HIV, and much more. Stay tuned.

Cognitum's Iosif M. Gershteyn discusses advances in gene editing with CRISPR and its' potential to develop a treatment for HIV with immunologist Dr. Leonardo...

04/24/2019

Agency recognizes growth of gene therapy as an option FDA Commissioner Scott Gottlieb, MD, released a statement last week to acknowledge and address the

03/23/2019

Today is XBIOSPACE’s 1st birthday and to celebrate we want to say that, 🐶 = ❤️. Happy National Puppy Day everyone!

03/22/2019

Why you should own your data.

A large consumer DNA test database, DNA, has quietly started allowing the FBI to upload genetic profiles created from crime scenes and corpses, according to Buzzfeed.